- Home
- SNOA vs PALI Comparison
SNOA vs PALI Comparison
Compare SNOA & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOA
- PALI
- Stock Information
- Founded
- SNOA 1999
- PALI 1996
- Country
- SNOA United States
- PALI United States
- Employees
- SNOA N/A
- PALI N/A
- Industry
- SNOA Biotechnology: Pharmaceutical Preparations
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNOA Health Care
- PALI Health Care
- Exchange
- SNOA Nasdaq
- PALI Nasdaq
- Market Cap
- SNOA 7.5M
- PALI 7.5M
- IPO Year
- SNOA 2007
- PALI N/A
- Fundamental
- Price
- SNOA $4.26
- PALI $0.60
- Analyst Decision
- SNOA
- PALI Strong Buy
- Analyst Count
- SNOA 0
- PALI 2
- Target Price
- SNOA N/A
- PALI $12.00
- AVG Volume (30 Days)
- SNOA 76.5K
- PALI 1.1M
- Earning Date
- SNOA 11-06-2025
- PALI 11-11-2025
- Dividend Yield
- SNOA N/A
- PALI N/A
- EPS Growth
- SNOA N/A
- PALI N/A
- EPS
- SNOA N/A
- PALI N/A
- Revenue
- SNOA $14,912,000.00
- PALI N/A
- Revenue This Year
- SNOA $23.00
- PALI N/A
- Revenue Next Year
- SNOA $24.59
- PALI N/A
- P/E Ratio
- SNOA N/A
- PALI N/A
- Revenue Growth
- SNOA 17.43
- PALI N/A
- 52 Week Low
- SNOA $1.75
- PALI $0.53
- 52 Week High
- SNOA $6.92
- PALI $4.32
- Technical
- Relative Strength Index (RSI)
- SNOA 48.08
- PALI 39.30
- Support Level
- SNOA $3.80
- PALI $0.55
- Resistance Level
- SNOA $4.68
- PALI $0.66
- Average True Range (ATR)
- SNOA 0.21
- PALI 0.04
- MACD
- SNOA -0.10
- PALI 0.01
- Stochastic Oscillator
- SNOA 47.42
- PALI 42.50
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.